These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 20938085

  • 1. Autoantibody profiles as biomarkers of breast cancer.
    Tabernero MD, Lv LL, Anderson KS.
    Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
    [Abstract] [Full Text] [Related]

  • 2. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.
    Bradford TJ, Wang X, Chinnaiyan AM.
    Urol Oncol; 2006; 24(3):237-42. PubMed ID: 16678056
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
    Fernández Madrid F.
    Cancer Lett; 2005 Dec 18; 230(2):187-98. PubMed ID: 16297705
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.
    Kalniņa Z, Siliņa K, Meistere I, Zayakin P, Rivosh A, Abols A, Leja M, Minenkova O, Schadendorf D, Linē A.
    J Immunol Methods; 2008 May 20; 334(1-2):37-50. PubMed ID: 18314130
    [Abstract] [Full Text] [Related]

  • 5. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
    Tamesa MS, Kuramitsu Y, Fujimoto M, Maeda N, Nagashima Y, Tanaka T, Yamamoto S, Oka M, Nakamura K.
    Electrophoresis; 2009 Jun 20; 30(12):2168-81. PubMed ID: 19582718
    [Abstract] [Full Text] [Related]

  • 6. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C, Bascoul-Mollevi C, Rochaix P, Lamy PJ, Kramar A, Rouanet P, Maudelonde T, Mangé A, Solassol J.
    Clin Cancer Res; 2009 Jul 15; 15(14):4733-41. PubMed ID: 19584157
    [Abstract] [Full Text] [Related]

  • 7. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
    Lu H, Goodell V, Disis ML.
    J Proteome Res; 2008 Apr 15; 7(4):1388-94. PubMed ID: 18311901
    [Abstract] [Full Text] [Related]

  • 8. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
    Yang Z, Chevolot Y, Géhin T, Solassol J, Mange A, Souteyrand E, Laurenceau E.
    Biosens Bioelectron; 2013 Feb 15; 40(1):385-92. PubMed ID: 23017679
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb 15; 12(2):136-43. PubMed ID: 12582023
    [Abstract] [Full Text] [Related]

  • 10. Autoantibodies in cancer: prognostic biomarkers and immune activation.
    Järås K, Anderson K.
    Expert Rev Proteomics; 2011 Oct 15; 8(5):577-89. PubMed ID: 21999829
    [Abstract] [Full Text] [Related]

  • 11. Identifying autoantibody signatures in cancer: a promising challenge.
    Desmetz C, Maudelonde T, Mangé A, Solassol J.
    Expert Rev Proteomics; 2009 Aug 15; 6(4):377-86. PubMed ID: 19681673
    [Abstract] [Full Text] [Related]

  • 12. Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women.
    Frenkel K, Karkoszka J, Glassman T, Dubin N, Toniolo P, Taioli E, Mooney LA, Kato I.
    Cancer Epidemiol Biomarkers Prev; 1998 Jan 15; 7(1):49-57. PubMed ID: 9456243
    [Abstract] [Full Text] [Related]

  • 13. SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma.
    Sun Y, Zhang R, Wang M, Zhang Y, Qi J, Li J.
    Cancer Epidemiol Biomarkers Prev; 2012 Nov 15; 21(11):2043-7. PubMed ID: 22832207
    [Abstract] [Full Text] [Related]

  • 14. A proteomic approach based on multiple parallel separation for the unambiguous identification of an antibody cognate antigen.
    Mun J, Kim YH, Yu J, Bae J, Noh DY, Yu MH, Lee C.
    Electrophoresis; 2010 Oct 15; 31(20):3428-36. PubMed ID: 20872419
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of proteomic strategies to identify antibodies resulting from the humoral immune response to cancer].
    Desmetz C, Mangé A, Solassol J.
    Med Sci (Paris); 2008 Dec 15; 24(12):1071-6. PubMed ID: 19116117
    [Abstract] [Full Text] [Related]

  • 16. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
    Yagihashi A, Ohmura T, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N.
    Clin Chim Acta; 2005 Dec 15; 362(1-2):125-30. PubMed ID: 16026775
    [Abstract] [Full Text] [Related]

  • 17. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
    Hamrita B, Chahed K, Kabbage M, Guillier CL, Trimeche M, Chaïeb A, Chouchane L.
    Clin Chim Acta; 2008 Jul 17; 393(2):95-102. PubMed ID: 18424265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.